A detailed history of Silvercrest Asset Management Group LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 168,472 shares of AMPH stock, worth $5.63 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
168,472
Previous 169,576 0.65%
Holding current value
$5.63 Million
Previous $6.78 Million 20.52%
% of portfolio
0.06%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.99 - $50.09 $40,836 - $55,299
-1,104 Reduced 0.65%
168,472 $8.18 Million
Q2 2024

Aug 14, 2024

SELL
$38.65 - $43.48 $6.55 Million - $7.37 Million
-169,576 Reduced 50.0%
169,576 $6.78 Million
Q2 2024

Aug 14, 2024

BUY
$38.65 - $43.48 $8.76 Million - $9.86 Million
226,724 Added 201.66%
339,152 $13.6 Million
Q1 2024

May 15, 2024

BUY
$42.85 - $63.45 $1.25 Million - $1.85 Million
29,182 Added 35.06%
112,428 $4.94 Million
Q3 2023

Nov 14, 2023

SELL
$45.51 - $65.0 $1.2 Million - $1.72 Million
-26,401 Reduced 24.08%
83,246 $3.83 Million
Q2 2023

Aug 14, 2023

SELL
$35.77 - $58.38 $1.62 Million - $2.64 Million
-45,221 Reduced 29.2%
109,647 $6.3 Million
Q1 2023

May 15, 2023

SELL
$27.99 - $37.92 $1.91 Million - $2.59 Million
-68,290 Reduced 30.6%
154,868 $5.81 Million
Q4 2022

Feb 14, 2023

SELL
$27.93 - $31.27 $55,804 - $62,477
-1,998 Reduced 0.89%
223,158 $6.25 Million
Q3 2022

Nov 14, 2022

SELL
$27.56 - $37.75 $168,667 - $231,030
-6,120 Reduced 2.65%
225,156 $6.33 Million
Q2 2022

Aug 15, 2022

SELL
$29.79 - $42.29 $310,560 - $440,873
-10,425 Reduced 4.31%
231,276 $8.05 Million
Q1 2022

May 16, 2022

SELL
$22.96 - $36.45 $2.92 Million - $4.64 Million
-127,250 Reduced 34.49%
241,701 $8.68 Million
Q3 2021

Nov 15, 2021

SELL
$17.83 - $21.49 $151,626 - $182,750
-8,504 Reduced 2.25%
368,951 $7.01 Million
Q2 2021

Aug 16, 2021

BUY
$17.11 - $20.92 $1.44 Million - $1.75 Million
83,873 Added 28.57%
377,455 $7.61 Million
Q1 2021

May 17, 2021

SELL
$17.21 - $20.65 $674,890 - $809,789
-39,215 Reduced 11.78%
293,582 $5.38 Million
Q4 2020

Feb 16, 2021

BUY
$17.76 - $21.24 $920,269 - $1.1 Million
51,817 Added 18.44%
332,797 $6.69 Million
Q3 2020

Nov 16, 2020

SELL
$17.99 - $22.22 $96,066 - $118,654
-5,340 Reduced 1.87%
280,980 $5.27 Million
Q2 2020

Aug 14, 2020

SELL
$14.25 - $22.46 $71,706 - $113,018
-5,032 Reduced 1.73%
286,320 $6.43 Million
Q1 2020

May 15, 2020

SELL
$12.66 - $20.08 $112,901 - $179,073
-8,918 Reduced 2.97%
291,352 $4.32 Million
Q4 2019

Feb 14, 2020

BUY
$17.07 - $20.64 $1.18 Million - $1.43 Million
69,229 Added 29.96%
300,270 $5.79 Million
Q3 2019

Nov 14, 2019

BUY
$19.12 - $22.62 $4.42 Million - $5.23 Million
231,041 New
231,041 $4.58 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.64B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.